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Abstract
Background: Leishmaniases are among the most proteiform parasitic infections in humans ranging from
unapparent to cutaneous, mucocutaneous or visceral diseases. The various clinical issues depend on
complex and still poorly understood mechanisms where both host and parasite factors are interacting.
Among the candidate factors of parasite virulence are the A2 genes, a family of multiple genes that are
developmentally expressed in species of the Leishmania donovani group responsible for visceral diseases
(VL). By contrast, in L. major determining cutaneous infections (CL) we showed that A2 genes are present
in a truncated form only. Furthermore, the A2 genomic sequences of L. major were considered
subsequently to represent non-expressed pseudogenes [1]. Consequently, it was suggested that the
structural and functional properties of A2 genes could play a role in the differential tropism of CL and VL
leishmanias. On this basis, it was of importance to determine whether the observed structural/functional
particularities of the L. major A2 genes were shared by other CL Leishmania, therefore representing a
proper characteristic of CL A2 genes as opposed to those of VL isolates.
Methods: In the present study we amplified by PCR and sequenced the A2 genes from genomic DNA and
from clonal libraries of the four Old World CL species comparatively to a clonal population of L. infantum
VL parasites. Using RT-PCR we also amplified and sequenced A2 mRNA transcripts from L. major.
Results: A unique A2 sequence was identified in Old World cutaneous Leishmania by sequencing. The
shared sequence was highly conserved among the various CL strains and species analysed, showing a single
polymorphism C/G at position 58. The CL A2 gene was found to be functionally transcribed at both
parasite stages.
Conclusion: The present study shows that cutaneous strains of leishmania share a conserved functional
A2 gene. As opposed to the multiple A2 genes described in VL isolates, the CL A2 gene is unique, lacking
most of the nucleotide repeats that constitute the variable region at the 5'end of the VL A2 sequences. As
the variable region of the VL A2 gene has been shown to correspond to a portion of the protein which is
highly immunogenic, the present results support the hypothesis of a possible role of the A2 gene in the
differential tropism of CL and VL leishmania parasites.
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Background
Leishmaniases are among the most important protozoan
infections that affect humans in the world. The disease is
widespread in 88 endemic countries with 350 million
people at risk, 12 million people permanently affected,
and an estimated annual incidence of 1.5–2 million cases
[2]. This results in a global morbidity of 2,357 thousands
DALYs (Disability Adjusted Life Years: number of healthy
years of life lost due to premature death and disability)
and a mortality rate of 59,000/year [3].
A surprisingly broad spectrum of clinical expressions is
observed in humans ranging from asymptomatic to cuta-
neous (CL), diffuse cutaneous, mucocutaneous and vis-
ceral (VL) diseases, and an intermediary form known as
post-Kala-Azar dermal leishmaniasis.
The various clinical issues of Leishmania infection depend
on a complex host-parasite relationships where both the
genetic or immunological status of the host [4-6] and the
proper parasite biodiversity in terms of tropism and viru-
lence [7,8] appear as determinant factors. A number of
parasitic factors have been identified as susceptible to play
a role in virulence/protection mechanisms in leishmani-
ases [9]. Among these, since its first identification in Leish-
mania infantum [10] several lines of evidence indicate that
the A2 gene/protein family could be one of the most eligi-
ble candidate factor of virulence in VL infections: i) A2-
proteins and mRNA transcripts are developementally
expressed at the amastigote intracellular stage while unde-
tectable in the promastigote [11], ii) Inhibition of A2-
expression in Leishmania donovani using anti-sense RNA or
by generation of partial knock-out mutants results in
reduced virulence in vivo, iii) by contrast, increased para-
site levels are observed in spleen of mice infected with A2-
expressing transfected L. major [11,12] iv) A protective
immunity can be achieved experimentally in mice by
immunization with recombinant A2 protein or DNA vac-
cination showing that A2 from L. donovani is highly
immunogenic and represents a potential antigen for pro-
tection in VL [13,14] and more recently in L. amazomensis
infections [15].
A2 genes were detected by karyotype analysis in L. dono-
vani,  L. infantum and L. chagasi (Old World and New
World VL) and in L. mexicana and L. amazonensis (New
World DCL and MCL, respectively) but not in cutaneous
species from the Old World (L. tropica, L. aethiopica and L.
major) and the New World (L. brasiliensis, L. guyanensis
and L. panamensis) [16]. Accordingly, A2-antibodies were
found in sera from human and dogs naturally infected
with L. chagasi (VL) [17] and in patients with VL in Sudan
and India and CL due to L. mexicana, while they were not
detected in L. tropica and L. brasiliensis infections (CL)
[16].
While long considered absent in the L. tropica group, we
identified by sequencing an A2 gene from crude PCR
products of two strains of L. major (AF532102, AF532103)
showing that the gene is present in L. major in a truncated
form lacking most of the repeated motives that are present
at the 3'end variable region of the VL A2 genes. Moreover,
the L. major A2 gene was found subsequently to be non
expressed and was considered to represent a pseudogene
[1].
These observations raised the question of a possible role
of the structure/functionality of A2 genes in the cutaneous
or visceral tropism of leishmania parasites. As no data were
available on the A2 gene of CL Leishmania except for L.
major, our objective was to investigate this gene in Old
World CL species. We amplified and sequenced A2-genes
of additional strains of Old World CL species and in a
clonal lineage of a L. infantum mediterranean strain iso-
lated from a VL patient. Our results show that: i) The A2
sequence is extremely conserved both among strains and
species of Old World CL Leishmania, ii) The CL A2 gene is
a single copy gene of only 153 base pairs (bp) encoding
for a protein of 51 amino acids, as opposed to A2 of VL
species that are multicopy genes of varying length, ii) The
CL A2 gene is functionally transcribed at the promastigote
and amastigote stages.
Methods
Parasites
Strains. Six strains of one visceral and four cutaneous Old
World  Leishmania  species were used for sequencing: L.
infantum and L. major, L. tropica, L. killicki and L. aethiop-
ica, respectively (Table I). Four of the five cutaneous
strains were reference strains recommended by the
W.H.O. [18]. In addition two L. donovani VL strains
LEM3467 and LEM3566 were used for PCR analysis. All
strains originated from the International Leishmania Cry-
obank and Identification Center, Montpellier, France.
Parasite clones. Parasite clonal lineages were obtained from
L. infantum MHOM/FR/92/LEM2385 and from L. major
MHOM/SU/73/5 ASKH strains using a microplate tech-
nique as previously described [19].
Culture and isolation. Promastigotes were cultivated at
27°C in HOSMEM liquid medium [20] supplemented
with hemin 10 µM (Sigma, Saint Quentin Fallavier,
France) and 10% fetal calf serum (Gibco, Cergy-Pontoise,
France). Parasites were inoculated into 25 ml culture
flasks at day 0 (d0) at a final concentration of 105 ml-1.
Amastigote organisms were isolated from foot-pad (L.
major) or spleen (L. infantum) of Balb/c mice inoculated
subcutaneously or intraveinously with 107 log-phase pro-
mastigotes, respectively. Parasites were washed twice in
PBS and counted in Malassez chambers.BMC Infectious Diseases 2005, 5:18 http://www.biomedcentral.com/1471-2334/5/18
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DNA extraction
Washed parasites (100 µl PBS / ≈ 109 parasites) were lysed
by thermal shock in Eppendorf tubes, 1 mn in boiling
water – 1 mn in melting ice, three times. DNA extraction
was performed using classical phenol/chloroform/iso-
amylic alcool protocol and precipitation was made using
NaCl/ethanol procedure. The DNA was dissolved in 40 µl
of sterile water.
PCR and sequencing
Amplification of the parasite DNA matrix (50 ng) was
made using L2/R3 primers (5'-TTGGCAATGCGAGCGT-
CACAGTC / 5'- CAACGCGTACGATAATGCCACA). The
L2/R3 primers correspond to the 5' end position 16301
and 16603 of the inverse-complementary strand of the
AC010851 sequence, respectively. The PCR was per-
formed in a reaction mixture of 50 µl containing either 1
or 3 mM MgCl2, 200 µM each dNTP, 25 pmol of each
primer (Proligo, Paris, France), 1 U Taq polymerase
(Eurogentec, Seraing, Belgium). L2/R3-PCR conditions
consisted to denaturation for 3 mn at 94°C, followed by
35 amplification cycles at 94°C for 1 mn, 1 mn at 58°C,
1 mn at 72°C, then one cycle at 72°C for 5 mn. Amplifi-
cation of cDNA from bacterial culture medium (0.5 µl)
was made using M13 forward-20 / M13 reverse (Qiagen
PCR cloning kit, Qiagen, Courtaboeuf, France) with 1 mM
MgCl2. M13 forward-20 / M13 reverse -PCR conditions
consisted in a hot-start denaturation for 10 mn 95°C, fol-
lowed by addition of 1 U Taq polymerase, 30 amplifica-
tion cycles at 94°C for 30 sec, 30 sec at 48°C, 1 mn at
72°C, then one cycle at 72°C for 5 mn. Five microliters of
PCR product was electrophoresed in 2% agarose gel in the
presence of ethidium bromide, and visualized under UV
light. A 50-bp ladder (Sigma) was used as MW marker.
For sequencing, the two strands of PCR-amplified DNA
were purified with QIAquick PCR Purification Kit (Qia-
gen) and sequenced with the corresponding PCR primer
set using the BigDye Terminator Sequencing Kit V3.1
(Applied Biosystems, Courtaboeuf, France) on an auto-
mated sequencer 3100 Genetic analyser (Applied
Biosystems).
RNA extraction and reverse transcription-PCR (RT-PCR)
L. major IPAP/MA/86/LEM898 total RNA was extracted
from promastigote cultures or infected organs (≈ 106-107
parasites) using Rneasy Plant Mini Kit (Qiagen). To elim-
inate any remaining DNA the RNA extract mixture (5 µl)
was additionnaly treated by Dnase Rnase-free (Eurogen-
tec) for 30 min at 37°C in a final volume of 30 µl. As a
negative control, an aliquote of the sample (5 µl) was sub-
sequently digested with Rnase A (Qiagen) 700 mg 1 h at
25°C in a final volume of 16 µl. RT was performed in a
total volume of 20 µl by 50-min incubation at 42°C fol-
lowed by 15 min at 70°C to inactivate the reverse tran-
scriptase. The reaction mixture contained a sixth of the
initial volume of the RNA extraction products, and the fol-
lowing final reagent concentrations: 1X hexanucleotide
mix (Roche, Meylan France), 500 µM dNTP mix, 40U
Rnase inhibitor, 1X first strand buffer, 100 mM
dithiothreitol, and 200 U Super Script II (Invitrogen,
Cergy Pontoise, France). Two microliters of RT products
were PCR-amplified with L2/R3 primer set.
DNA libraries
L2/R3-PCR products from genomic DNA matrix were syn-
thetized as described above except for the MgCl2 concen-
tration (3 mM). PCR products were purified on QIAquick
column (Qiagen). Poly-A treatment, insertion of the PCR
products into pDrive vector, transformation of E. coli EZ
Table 1: 
Tropism Species Strain Zymodeme Allele type GeneBank accession number
gDNA2 mRNA Protein3
Visceral (LV) L. infantum MHOM/FR/92/ LEM2385 Cl 1 MON-29 II AY255807 AAP21103
III AY255808 AAP21104
IV AY255809 AAP21105
Cutaneous L. major IPAP/MA/86/ LEM898 MON-25 I.1 AF5321022 AY25581 AAM95954
MHOM/SU/73/ 5 ASKH1 MON-4 I.2 AY185122 AAP21106
AAO27297
(LC) L. aethiopica MHOM/ET/72/ L1001 MON-14 I.1 AY255804 AAP21100
L. killicki MHOM/TN/86/ LEM904- CL1 MON-8 I.1 AY255805 AAP21101
L. tropica MHOM/SU/74/ K271 MON-60 I.1 AY255806 AAP21102
1WHO recommended reference strains. 2 Direct genomic DNA sequencing.
3Predicted protein.
Strains originated from the International Leishmania Cryobank and Identification Center, Montpellier, France.BMC Infectious Diseases 2005, 5:18 http://www.biomedcentral.com/1471-2334/5/18
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competent cells (Qiagen) and cloning were performed
using a PCR Cloning Kit (Qiagen) as described by the sup-
plier. A2-containing genomic clones were screened by
digestion of M13-PCR products with Sau3AI endonucle-
ase (BioLabs, Saint Quentin en Yvelines, France) which
cuts off A2-gene nucleotidic sequences at position 33–34
(reference : L. major MHOM/IR/-/173; AF532103).
GeneBank accession numbers
Accession numbers for genomic DNA, mRNA and puta-
tive protein sequences are given in Table I.
Results
PCR
L2/R3 PCR products obtained from parasite crude
genomic DNA resolved in different electrophoretic pat-
terns, according to the species. For all CL isolates (Fig. 1-
A) one single band of about 260 bp was evidenced when
PCR was performed using stringent or not stringent con-
ditions (1 or 3 mM Mgcl2), thus these products were avail-
able for direct sequencing. By contrast PCR amplification
products could be obtained only under non stringent con-
ditions (3 mM MgCl2) for VL species, resolving in a com-
plex electrophoresis pattern (Fig. 1-B). These products
were shown by direct sequencing to be a mixture of A2
sequences and of non specific products resulting probably
from a certain degree of mispriming due to non stringent
conditions. As a consequence direct sequencing of L2R3
PCR products from crude genomic DNA of VL species
could not be performed, thus A2 sequences were obtained
from clone libraries of L. infantum MHOM/FR/92/
LEM2385-clone 1.
The PCR performed with M13 primers on clone libraries
corroborated the above results. All genomic-DNA clones
originating from L. major, L. tropica, L. aethiopica and L. kil-
licki resolved in a unique band of 300 bp. By contrast,
three different bands of 370, 410 and 460 bp were identi-
fied from the L. infantum clone library (data not shown).
Only 1/4 of the library clones (20 clones were sequenced)
corresponded to cloned A2-gene. The other clones
corresponded to unknown or microsatellite structures (3
clones) in BLAST analysis study.
Sequencing (Fig. 2)
Old-World CL strains
A single sequence of 258 nucleotides was evidenced by
directly sequencing the crude L2/R3-PCR products of the
genomic-DNA of the three L. major strains. The three
sequences were found identical with the exception of a
single polymorphism C/G at position 58 for the L. major
134 and 173 as compared with L. major 898. Additional
PCR electrophoresis patterns Figure 1
PCR electrophoresis patterns. Electrophoretic patterns of PCR products obtained from crude parasite genomic DNAs 
using 3 mM MgCl2. A. CL isolates: 1, L. major LEM898; 2, L. major LEM134; 3, L. aethiopica LEM144; 4, L. tropica LEM419; 5, L. kil-
licki LEM904; Light arrow: A2 gene. B. VL isolates: 1, L. infantum LEM2385-cl1; 2, L. donovani LEM3467-cl3 3; L. donovani 
LEM3566; square bracket: A2-gene area.
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nucleotide sequences from 32 genomic clones of the
above mentioned L. major strains were all identical to the
corresponding crude sequences. Moreover, the sequences
obtained from crude L2/R3-PCR products and from 15
genomic clones of L. aethiopica, L. tropica and L. killicki
were totally identical to the L. major-898 sequence. These
sequences were referred to as A2-gene allele typeI.1 and
I.2, respectively.
L. infantum VL strain
Three A2-gene sequences of 371, 413 and 464 nucleotides
were isolated from the genomic library of L. infantum
MHOM/FR/92/LEM2385 clone 1 (L.  infantum-2385.1).
These sequences were referred to as A2 type II-, III- and IV-
alleles.
Comparative analysis of A2-gene alleles from CL (type I)
and VL (Type II, III and IV) strains showed that the genes
are composed of a common nucleotide sequence at the 5'
end followed by a region of varying length inserted from
the position 97 of the ORF to the 3' end which is a stretch
of a number of more or less conserved repeated nucle-
otide patterns.
mRNA expression
Results of RT-PCR on Dnase-treated L. major IPAP/MA/
86/LEM898 mRNA extracts are presented in Fig. 3. A sin-
gle band was evidenced in RT-PCR products from both
promastigotes and foot pads of infected mice. A faint
band was also observed in popliteal lymph node extracts
(data not shown). The sequencing of the RT-PCR cDNA
product resulted in a 258-nucleotide sequence
(AY255810) identical to the sequence obtained from the
crude genomic DNA, and corresponding to a putative A2
protein of 51 AA.
Discussion
Leishmania A2-genes were first identified in two strains of
the L. donovani complex, L. infantum LV9 and L. donovani
1S2D determining visceral infections [10,21]. In these VL
strains A2 genes were shown to be organized in several
clusters each comprising multiple A2 genes of varying
length that are tandemly associated with related
sequences (A2rel) [10,11,22]. However, these results were
obtained from leishmania strains isolated from naturally
infected hosts which are known to be most likely com-
posed of multiple parasite populations [23,24]. Therefore,
the existence of multiple A2 genes remained to be con-
firmed using a genetically pure parasite clonal lineage. As
in the present study three different A2-alleles type II, III
and IV were sequenced from the L. infantum MHOM/FR/
92/LEM2385 Clone-1 genomic library, our results provide
additional evidence that A2 of VL species is a multiple
gene family. Alleles type I, II and III differ only in the
number and arangement of the repeated motives at the
3'end variable region of the gene as previously described
in VL strains [10]. However, in the present study we iden-
tified A2 sequences showing a limited number of repeats
and consequently a length of only 371 to 464 bp contrast-
ing with the previously published A2 genes of about 700–
800 bp. The inability to evidence A2 sequences > 1 kb in
the present study is most probably due to the limits of the
A2 nucleotide sequences Figure 2
A2 nucleotide sequences. Leishmania major IPAP/MA/86/LEM 898 and MHOM/SU/73/5 ASKH LEM134 (allele types I.1 and 
I.2) and Leishmania infantum MHOM/FR/92/LEM2385 clone 1 (allele types II to IV). Internal nucleotide repeats are shown in 
blue. The polymorphism C/G at position 58 is highlighted in yellow.
 CACACCCGCACAGCTTTGAACTAGCATA ATG AAGATCTGCAGCGTGCGTCCGCTTGTCGTGTTGCTGGTGTGCGTCGCCGCGATGCTCGCACTCAGCGCCTCCGCTGAGCCGCACAAGGCAGCC    124 
 --CACCCGCACAGCTTTGAACTAGCATA ATG AAGATCTGCAGCGTGCGTCCGCTTGTGGTGTTGCTGGTGTGCGTCGCCGCGATGCTCGCACTCAGCGCCTCCGCTGAGCCGCACAAGGCAGCC    122 
 CCCCCACGCACAACATTGACCGAGCACA ATG AAGATCCGCAGCGTGCGTCCGCTTGTGGTGTTGCTGGTGTGCGTCGCGGCGGTGCTCGCACTCAGCGCCTCCGCTGAGCCGCACAAGGCGGCC    124 
. CCCCCACGCACAACATTGACCGAGCACA ATG AAGATCCGCAGCGTGCGTCCGCTTGTGGTGTTGCTGGTGTGCGTCGCGGCGGTGCTCGCACTCAGCGCCTCCGCTGAGCCGCACAAGGCGGCC    124 
 CCCCCACGCACAACATTGACCGAGCACA ATG AAGATCCGCAGCGTGCGTCCGCTTGTGGTGTTGCTGGTGTGCGTCGCGGCGGTGCTCGCACTCAGCGCCTCCGCTGAGCCGCACAAGGCGGCC    124 
GTTGACGTCGGAACGCTCTCT --------------------- --------------------- --------------- --------------- --------------- --------------- 145 
GTTGACGTCGGAACGCTCTCT --------------------- --------------------- --------------- --------------- --------------- --------------- 143 
GTTGACGTCGGCCCGCTCTCT GTTGACGTTGGCCCGCTCTCT --------------------- GTTGGCCCGCAGTCC GTCGGCCCGCTCTCC GTTGGCCCGCAGGCT GTTGGCCCGCTCTCC 226 
. GTTGACGTCGGCCCGCTCTCT GTTGACGTCGGCCCGCTCTCT GTTGACGTTGGCCCGCTCTCC GTTGGTCCGCAGTCT GTTGGCCCGCTCTCC GTTGGCCCGCAGTCT GTTGGCCCGCTCTCT 247 
GTTGACGCCGGCCCGCTCTCT GTTGACGTCGGCCCGCTCTCT GTTGACGTTGGCCCGCTCTCC GTTGGTCCGCAGTCT GTTGGCCCGCTCTCC GTTGGCCCGCAGTCT GTTGACCCGCTCTCT 247
 --------------------- --------------- --------------- --------------------- --------------- --------------- GTGGGCCTGCAGGCC       160 
 --------------------- --------------- --------------- --------------------- --------------- --------------- GTGGGCCTGCAGGCC       160 
 --------------------- --------------- --------------- --------------------- GTTGGTCCGCAGTCC GTTGGCCCGCTCTCG GTTGGCCTGCAGGCT       271 
. --------------------- --------------- --------------- GTTGACGTTGGCCCGCTCTCC GTTGGTCCGCAGTCT GTTGGCCCGCTCTCC GTTGGTCCGCAGTCC       313 
GTTGACGTTGGCCCGCTCTCC GTTGGTCCGCAGTCT GTTGGCCCGCTCTCT GTTGACGTTGGCCCGCTCTCC GTTGGTCCGCAGTCC GTTGGCCCGCTCTCG GTTGGCCTGCAGGCT       364 
GTTGACGTTGGCCCGGTGTCG TAA GACTCGGCGTCCGCTTTCCGGCCTGCAGGAAAGCATGT--CATGGGGCATGGCGAAGCCTCGAACCTTGTCAGCAA                            258 
GTTGACGTTGGCCCGGTGTCG TAA GACTCGGCGTCCGCTTTCCGGCCTGCAGGAAAGCATGT--CATGGGGCATGGCGAAGCCTCGAACCTTGTCAGCAA                            256 
GTTGACGTTTCTCCGGTGTCT TAA GGCTCGGCGTCCGCTTTCCGGTGTGCGTAAAAGTATATGCCATGAGGCATGGTGACGAGGCAAACCTTGTCAGCAG                            371 
. GTTGACGTTTCTCCGGTGGCT TAA GGCTCGGCGTCCGCTTTCCGGTGTGCGTAAAAGTATATGCCATGAGGCATGGTGACGAGGCAAACCTTGCCAGCAA                            413 
GTTGACGTTTCTCCGGTGTCT TAA GGCTCGGCGTCCGCTTTCCGGTGTGCGTAAAAGTATATGCCATGAGGCATGGTGACGAGGCAAACCTTGTCAGCAG                            464 BMC Infectious Diseases 2005, 5:18 http://www.biomedcentral.com/1471-2334/5/18
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PCR technique performed on crude genomic parasite
DNA or to the absence of long A2 sequences in this strain.
Thus these results are not contradictory to the previously
published data but bring additional information on the
variability of the L. infantum A2 genes.
We previously identified A2 sequences in two strains of L.
major  IPAP/MA/86/LEM898 and MHOM/IR/00/173
(AF532102 and AF532103, respectively). These sequences
were 95% (88 nt/93) identical to the S69693 stage-spe-
cific S antigen homolog (A2) of L. infantum VL [10] at the
5'-end of the ORF (nucleotides 74 to 167). By contrast, a
major deletion of the 3'end variable region of repeated
nucleotide motives was observed in L. major A2 genes.
In the present study, the amplification of Old World Leish-
mania  genomic DNA with L2/R3 A2-gene primer set
resolved in a single amplification product on gel electro-
phoresis, as opposed to the complex pattern observed
with L. infantum. Accordingly, a single sequence of 258
nucleotides was obtained by direct sequencing crude DNA
products from all CL Leishmania, whatever the strain or
species. A common sequence was also isolated from 32
genomic clones of L. major LEM898 and 15 clones of L.
tropica, L. aethiopica and L. killicki. The A2 sequence shared
by all strains and species of Old World leishmania pre-
sented a single polymorphism C/G at position 58 of the
ORF. These results show for the first time that the A2 gene
of Old World cutaneous Leishmania is unique and highly
conserved, contrasting strongly with the multiple A2
sequences of varying length observed in VL isolates.
RT-PCR on mRNA extracts from strain IPAP/MA/86/
LEM898 followed by sequencing evidenced that the CL A2
gene is functional. It is noteworthy that this finding does
not presume of the expression of the protein at the post-
transcriptional level, however it contrasts with the previ-
ous suggestion based on the failure to demonstrate A2
gene transcripts in L. major that the A2-gene of L. major is
a non-expressed pseudogene [1]. RT-PCR amplification of
RT-PCR on IPAP/MA/86/LEM898 strain Dnase-treated mRNA extracts Figure 3
RT-PCR on IPAP/MA/86/LEM898 strain Dnase-treated mRNA extracts. Additional Rnase-digestion (1–3). Unin-
fected spleen (1,4); Cultured promastigotes (2,5); Foot-pad (3,6). Controls: Genomic DNA (7); H2O (8). Arrow : A2 mRNA 
transcripts.
12345678
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both promastigote and amastigote mRNAs resulted in a
similar signal on gel electrophoresis in the present study,
showing that L. major A2-gene is transcribed at both amas-
tigote and promastigote stages. However, these results do
not signify that L. major A2 are not developmentally
expressed since RT-PCR is not quantitative. Actually, L.
infantum promastigotes were reported to express very low
levels of A2 [10,22].
Conclusion
The present study evidence that Old World cutaneous spe-
cies of Leishmania share a common, highly conserved and
functional A2 gene. In CL Leishmania the A2 gene is a sin-
gle gene in which the 3'end variable region is almost
entirely deleted, contrasting with VL A2 genes that are a
family of multiple genes where the 3'end portion is a var-
iable stretch of nucleotide repeats. Further investigations
are needed for exploring the potential role of theses struc-
tural differences between CL and VL A2 genes in govern-
ing both the proper parasite virulence/tropism and host
susceptibility/protection response conditioning the mul-
tiple clinical issues observed in human Leishmania infec-
tions.
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